Viewing Study NCT00888069

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-06-11 @ 1:42 PM
Study NCT ID: NCT00888069
Status: COMPLETED
Last Update Posted: 2014-09-30
First Post: 2009-04-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
Sponsor: OPKO IP Holdings II, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease View
None Secondary Hyperparathyroidism View
None Chronic Renal Insufficiency View
None Chronic Renal Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Parathyroid Diseases View
None Renal Insufficiency View
None Kidney Failure, Chronic View
None Hyperparathyroidism, Secondary View
None Vitamin D View
None Hyperparathyroidism View
None Renal Insufficiency, Chronic View
None Kidney Diseases View
None Kidney Failure View